Tower Research Capital (TRC)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,716
| Closed | -$3.09M | – | 6663 |
|
|
2021
Q2 | $3.09M | Buy |
18,716
+16,415
| +713% | +$2.74M | 0.08% | 181 |
|
|
2021
Q1 | $353K | Sell |
2,301
-7,121
| -76% | -$967K | 0.01% | 1529 |
|
|
2020
Q4 | $1.18M | Buy |
9,422
+7,499
| +390% | +$839K | 0.04% | 430 |
|
|
2020
Q3 | $195K | Sell |
1,923
-26,008
| -93% | -$2.65M | ﹤0.01% | 2605 |
|
|
2020
Q2 | $2.72M | Buy |
27,931
+25,953
| +1,312% | +$2.42M | 0.11% | 151 |
|
|
2020
Q1 | $164K | Buy |
+1,978
| New | +$193K | 0.01% | 833 |
|
|
2019
Q4 | – | Sell |
-1,015
| Closed | -$101K | – | 4749 |
|
|
2019
Q3 | $101K | Buy |
1,015
+91
| +10% | +$9.04K | 0.01% | 1342 |
|
|
2019
Q2 | $92K | Sell |
924
-2,633
| -74% | -$251K | 0.01% | 1220 |
|
|
2019
Q1 | $392K | Buy |
+3,557
| New | +$372K | 0.02% | 754 |
|
|
2018
Q4 | – | Sell |
-4,993
| Closed | -$550K | – | 4593 |
|
|
2018
Q3 | $550K | Buy |
4,993
+4,588
| +1,133% | +$478K | 0.04% | 432 |
|
|
2018
Q2 | $38K | Sell |
405
-2,622
| -87% | -$226K | ﹤0.01% | 2032 |
|
|
2018
Q1 | $251K | Buy |
+3,027
| New | +$269K | 0.02% | 779 |
|
|
2017
Q4 | – | Sell |
-5,758
| Closed | -$439K | – | 4252 |
|
|
2017
Q3 | $439K | Buy |
+5,758
| New | +$435K | 0.04% | 301 |
|
|
2017
Q2 | – | Sell |
-1,242
| Closed | -$81K | – | 3732 |
|
|
2017
Q1 | $81K | Buy |
+1,242
| New | +$73.2K | 0.01% | 534 |
|
|
2016
Q1 | – | Sell |
-409
| Closed | -$19K | – | 5247 |
|
|
2015
Q4 | $19K | Buy |
+409
| New | +$17.2K | ﹤0.01% | 1369 |
|
|
2015
Q3 | – | Sell |
-349
| Closed | -$13K | – | 5068 |
|
|
2015
Q2 | $13K | Sell |
349
-113
| -24% | -$3.57K | ﹤0.01% | 2490 |
|
|
2015
Q1 | $13K | Sell |
462
-630
| -58% | -$17.6K | ﹤0.01% | 2595 |
|
|
2014
Q4 | $26K | Buy |
+1,092
| New | +$24.6K | ﹤0.01% | 1428 |
|
Other funds holding PRAH
Tower Research Capital (TRC)'s PRAH Position: Q3 2021 in Review
Tower Research Capital (TRC) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 18,716 shares — an estimated $3.09M sold.
Tower Research Capital (TRC) first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $3.09M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Tower Research Capital (TRC) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 18,716 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.09M.
- Tower Research Capital (TRC) first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
- Tower Research Capital (TRC)'s PRA Health Sciences, Inc. position peaked at $3.09M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.